• Source: Apricoxib

Apricoxib is an experimental anticancer drug and nonsteroidal anti-inflammatory drug (NSAID). It is a COX-2 inhibitor which is intended to improve standard therapy response in molecularly-defined models of pancreatic cancer. It was also studied in clinical trials for non-small-cell lung cancer. Development was abandoned in 2015 due to poor clinical trial results.




See also


Tilmacoxib
Cimicoxib
NS-398
Celecoxib




References

Kata Kunci Pencarian:

• Aprikoksib
• Apricoxib
• List of sulfonamides
• List of drugs: An–Ap
• Paracetamol
• Nonsteroidal anti-inflammatory drug
• Mefenamic acid
• Ibuprofen
• Salicylic acid
• Resveratrol
• Prostaglandin